Decision-Making Tool for Blood Thinners
(DDInteract Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this project is to implement and evaluate a shared-decision making (SDM) tool called DDInteract that was developed to support decision making for drug-drugs interactions while on oral anticoagulants. DDInteract will be implemented in clinics at the University of Utah, University of Colorado and University of Vanderbilt. DDInteract will be launched from within the electronic health record (EHR) retrieving patient-specific risk factors, will calculate the risk of harm, and will allow providers and patients to dynamically explore "what if" scenarios to optimize treatment and minimize risk. DDInteract will enable shared-decision making using individually-tailored information on the potential benefits and harms of drug interactions in anticoagulated patients.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It focuses on helping you and your doctor make informed decisions about drug interactions with blood thinners.
Is the blood thinner treatment generally safe for humans?
How is the DDInteract tool different from other treatments for managing blood thinners?
What data supports the effectiveness of the treatment DDInteract?
Who Is on the Research Team?
Daniel C Malone, PhD
Principal Investigator
College of Pharmacy. University of Utah
Are You a Good Fit for This Trial?
This trial is for adults over 21 who are prescribed oral anticoagulants like warfarin or apixaban and take more than one medication. It's not suitable for those who can't communicate in English or Spanish.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline period to assess initial risk of gastrointestinal bleeding before DDInteract implementation
Implementation
Implementation of DDInteract tool in clinics to evaluate its effectiveness in mitigating drug interactions
Follow-up
Participants are monitored for safety and effectiveness after the implementation of DDInteract
What Are the Treatments Tested in This Trial?
Interventions
- DDInteract
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator